1
|
Crosetti E, Arrigoni G, Manca A, Caracciolo A, Bertotto I, Succo G. 3D Exoscopic Surgery (3Des) for Transoral Oropharyngectomy. Front Oncol 2020; 10:16. [PMID: 32082996 PMCID: PMC7006030 DOI: 10.3389/fonc.2020.00016] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2019] [Accepted: 01/07/2020] [Indexed: 12/14/2022] Open
Abstract
Over the past three decades, the incidence of oropharyngeal squamous cell carcinoma has increased, primarily related to the spread of human papillomavirus. Treatment has always been preferentially unimodal (surgery or radiotherapy) for early stage disease and multimodal (surgery with adjuvant therapy or concomitant chemoradiotherapy) for advanced stages. Recently, the surgical approach has gained renewed interest due to the morbidity of non-surgical treatments and also to technical innovations. We have coined the term 3Des (3D exoscope surgery) to describe the use of the 3D Vitom Exoscope System for transoral surgery of oropharyngeal cancers. During the period from June 2017 to May 2018, 10 patients with oropharyngeal cancer were treated by oropharyngeal surgery with the 3Des approach at FPO IRCCS Institute of Candiolo. The aim of the present prospective study was to evaluate the utility of 3Des for the treatment of early-stage oropharyngeal cancer. 3Des could represent a viable alternative to the operating microscope and robotic surgery thanks to its excellent ability to provide 3D visual information, depth of field, magnification, image contrast, color imaging, and low running costs. It promises great utility in the learning process, with the possibility of recording in high definition.
Collapse
Affiliation(s)
- Erika Crosetti
- Head and Neck Oncology Service, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy
| | - Giulia Arrigoni
- Head and Neck Oncology Service, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy
| | - Andrea Manca
- Head and Neck Oncology Service, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy
| | - Alessandra Caracciolo
- Head and Neck Oncology Service, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy
| | - Ilaria Bertotto
- Radiology Unit, Surgery Department, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy
| | - Giovanni Succo
- Head and Neck Oncology Service, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.,Department of Oncology, University of Turin, Orbassano, Italy
| |
Collapse
|
2
|
Shenouda K, Rubin F, Garcia D, Badoual C, Bonfils P, Laccourreye O. Evaluation of robotic surgery for transoral resection of T1-2 squamous cell carcinoma of the tonsillar fossa. Eur Ann Otorhinolaryngol Head Neck Dis 2019; 137:31-36. [PMID: 31561975 DOI: 10.1016/j.anorl.2019.09.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
GOAL To evaluate transoral robotic surgery (TORS) for isolated previously untreated squamous cell carcinoma (SCC) of the tonsillar fossa classified as T1-2. METHOD Retrospective analysis of two cohorts of isolated untreated T1-2 tonsillar fossa SCC consecutively operated on by a transoral approach, with (R=21) and without (NR=24) robotic assistance, in the period 2006-2014. Three main (survival, local control, and operative morbidity) and three secondary (pathologic data, incidence and duration of tracheotomy and nasogastric intubation, and hospital stay) endpoints were compared between groups. The significance threshold was set at P< .005. RESULTS Three- and five-year actuarial survival estimates were 80.2% and 74.5% respectively in group R, and 91.5% and 82.5% respectively in group NR (NS: P=.34). Three- and five-year actuarial local control estimates were 90% and 90% respectively in group R, and 95.8% and 91% respectively in group NR (NS: P=.81). There were no significant differences in morbidity, tracheotomy/nasogastric intubation time, or hospital stay. Positive resection margins (R1) were noted in 38.1% and 16.7% in groups R and NR, respectively (NS: P=.05) without significant impact on 5-year actuarial local control (P=0.78). CONCLUSION Robotic assistance in transoral lateral oropharyngectomy for T1-2 tonsillar fossa SCC did not significantly impact oncologic or functional outcome.
Collapse
Affiliation(s)
- K Shenouda
- Service d'otorhinolaryngologie, HEGP, université Paris-Descartes Sorbonne Paris-Cité, AP-HP, 20-40, rue Leblanc, 75015 Paris, France
| | - F Rubin
- Clinique St-Vincent, 97404 Saint-Denis cedex, Reunion
| | - D Garcia
- Clinique d'Arcachon, 33164, La Teste de Buch, France
| | - C Badoual
- Service d'anatomopathologie, HEGP, université Paris-Descartes Sorbonne Paris-Cité, AP-HP, 75015 Paris, France
| | - P Bonfils
- Service d'otorhinolaryngologie, HEGP, université Paris-Descartes Sorbonne Paris-Cité, AP-HP, 20-40, rue Leblanc, 75015 Paris, France
| | - O Laccourreye
- Service d'otorhinolaryngologie, HEGP, université Paris-Descartes Sorbonne Paris-Cité, AP-HP, 20-40, rue Leblanc, 75015 Paris, France.
| |
Collapse
|
3
|
Kwan BY, Khan NM, Almeida JR, Goldstein D, Paleri V, Forghani R, Yu E. Transoral robotic surgery for head and neck malignancies: Imaging features in presurgical workup. Head Neck 2019; 41:4018-4025. [DOI: 10.1002/hed.25887] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2019] [Revised: 07/01/2019] [Accepted: 07/11/2019] [Indexed: 12/14/2022] Open
Affiliation(s)
- Benjamin Y.M. Kwan
- Department of RadiologyQueen's University Kingston Ontario Canada
- Princess Margaret Cancer CenterUniversity of Toronto Toronto Ontario Canada
| | | | - John R. Almeida
- Princess Margaret Cancer CenterUniversity of Toronto Toronto Ontario Canada
| | - David Goldstein
- Princess Margaret Cancer CenterUniversity of Toronto Toronto Ontario Canada
| | - Vinidh Paleri
- Head and Neck UnitRoyal Marsden NHS Hospital London UK
| | - Reza Forghani
- Department of RadiologyMcGill University Montreal Quebec Canada
| | - Eugene Yu
- Princess Margaret Cancer CenterUniversity of Toronto Toronto Ontario Canada
| |
Collapse
|
4
|
Carsuzaa F, Thariat J, Gorphe P, Righini C, Cosmidis A, Thureau S, Roge M, De Mones E, Servagi-Vernat S, Tonnerre D, Morinière S, Dugas A, Malard O, Pasquier F, Vergez S, Salleron J, Dufour X. Surgery or Radiotherapy of the Primary Tumor in T1-2 Head and Neck Squamous Cell Carcinoma with Resectable N3 Nodes: A Multicenter GETTEC Study. Ann Surg Oncol 2019; 26:3673-3680. [PMID: 31264120 DOI: 10.1245/s10434-019-07589-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Indexed: 11/18/2022]
Abstract
BACKGROUND The prognosis of advanced nodal (N3) squamous cell carcinoma of the head and neck (HNSCC) is poor. We investigated whether surgery or radiotherapy of early (T1-2) primary stage HSNCC is preferable to limit the overall morbidity after upfront neck dissection (uND) for N3 disease. METHODS This retrospective multicentric Groupe d'Étude des Tumeurs de la Tête Et du Cou study included patients undergoing uND and surgery or radiotherapy of their primary. Prognostic factors were evaluated using propensity score matching to account for biases in performing surgery depending on primary site and stage. RESULTS Of 189 T1-2, N3 HNSCC patients, 70 (37.0%) underwent uND: 42 with surgery of their primary and 28 with radiotherapy only. Radiotherapy alone was more frequent in patients with hypopharyngeal primaries. All local (N = 3) and regional (N = 10) relapses (included 2 locoregional relapses) occurred within the first 2 years. There were 16 distant metastatic failures. Five-year locoregional relapse and survival incidences were 15.7% and 66.5% and were similar regardless of the treatment of the primary. The overall morbidity rate was 65.2% and was similar after weighting by the inverse propensity score (p = 0.148). The only prognostic factor for morbidity was the radicality of the uND. Prolonged parenteral feeding was not more frequent in patients only irradiated to their primary (p = 0.118). Prolonged tracheostomy was more frequent after surgery of the primary. CONCLUSIONS In patients with T1-2, N3 HNSCC undergoing uND, radiotherapy and surgery of the primary yield similar oncological outcomes. Morbidity was related to the extent of neck dissection.
Collapse
Affiliation(s)
- Florent Carsuzaa
- ENT, Service ORL, Chirurgie cervico-maxillo-faciale et audiophonologie, CHU de Poitiers, 2 rue de la Milétrie, 86000, Poitiers, France
| | | | - Philippe Gorphe
- Department of Head and Neck Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France
| | | | | | | | | | | | | | - Denis Tonnerre
- ENT, Service ORL, Chirurgie cervico-maxillo-faciale et audiophonologie, CHU de Poitiers, 2 rue de la Milétrie, 86000, Poitiers, France
| | | | | | | | | | - Sébastien Vergez
- ENT, Institut Universitaire du Cancer de Toulouse Oncopole - CHU de Toulouse, Toulouse, France
| | - Julia Salleron
- Cellule Data Biostatistique, Institut de Cancérologie de Lorraine, Université de Lorraine, Vandœuvre-Lès-Nancy, France
| | - Xavier Dufour
- ENT, Service ORL, Chirurgie cervico-maxillo-faciale et audiophonologie, CHU de Poitiers, 2 rue de la Milétrie, 86000, Poitiers, France.
| |
Collapse
|
5
|
Styloglossus muscle: a critical landmark in head and neck oncology. Eur Ann Otorhinolaryngol Head Neck Dis 2018; 135:421-425. [PMID: 30341015 DOI: 10.1016/j.anorl.2017.11.012] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2017] [Revised: 10/31/2017] [Accepted: 11/06/2017] [Indexed: 01/07/2023]
Abstract
GOAL To document the role of the styloglossus muscle (SG) in head and neck oncology and at the time of surgical treatment and mandibular preservation surgery for squamous cell carcinoma of the lateral oropharynx (SCCLO). METHOD Based on a search conducted within the Pubmed, Embase, and Cochrane databases, using the key words SG muscle, parapharyngeal space and oropharynx, the authors discuss the embryology, physiology, anatomy and radiology of this muscle as well as its role in the oncologic staging surgery of SCCLO. RESULTS The most specific radiologic exam to evaluate the involvement of SG muscle in SCCLO is magnetic resonance imaging (MRI). According to the eigth international staging classification systems, radiologic invasion of the SG muscle, at the time of MRI, leads to reclassify as T4a many tumors considered as T1-3 at the time of clinical and/or on computerized tomography evaluation. This must lead to extreme care when comparing oncologic results from series published prior and after the MRI era. When transoral resection of the SG muscle is advocated for SCCLO, one must know that this maneuver brings numerous arterial and venous structures within the operative field. If difficulties to achieve safe margins of resection and/or to control bleeding are encountered, a simple trans cervical maneuver described herein is most useful. CONCLUSION The importance of the SG muscle should be emphasized as a touchstone for staging and surgeon's guide to mandibular preservation surgery of SCCLO. The various approaches allowing the control of this muscle and its vascular environment must be taught at the time of initial training.
Collapse
|